Revalidation as a Program Integrity Tool
Revalidation as a Program Integrity Tool
For healthcare fraud, waste, and abuse (FWA) programs, provider oversight is a core program integrity function, and revalidation is one of the most effective tools for identifying emerging provider risk. Done well, it helps organizations detect risk earlier, reduce improper payments, and make stronger oversight decisions.
By confirming that provider information, eligibility, and risk status remain current, revalidation gives investigative and medical review teams a practical way to detect meaningful changes and act before they become larger payment integrity concerns.
It can also surface risks traditional recredentialing may miss, including sanctions, ownership changes, enrollment discrepancies, and billing anomalies. This article explains what revalidation is, how it differs from recredentialing, and why it deserves a more prominent role in a modern program integrity strategy.
What Is Revalidation?
Revalidation is a risk-triggered re-screening discipline that payers can use to confirm that provider enrollment, participation, and billing eligibility information remains current, accurate, and supportable. It draws on enrollment integrity principles reflected in CMS revalidation requirements, but functions as a payer oversight control, rather than a formal Medicare or Medicaid process.
The review verifies that a provider’s status, affiliations, and oversight profile continue to support participation and reimbursement. More than a check-the-box exercise, it identifies changes that may affect compliance, payment risk, or the need for further review.
A revalidation review commonly includes the following activities:
Enrollment and billing eligibility verification
Exclusion, sanction, and adverse action screening
Ownership, control, and affiliation review
Assessment of operational legitimacy and risk indicators relevant to FWA oversight
💡 Together, these activities help organizations evaluate both compliance requirements and meaningful risk signals in the same review.
What Is Recredentialing?
Recredentialing is a periodic review used to confirm that a provider continues to meet network participation standards, such as licensure, training, certification, and other credentialing requirements.
It helps organizations determine whether a provider should remain in the network based on established criteria. While important for administration and quality, it is not typically designed to identify evolving billing, enrollment, or affiliation-related risks the way revalidation can.
The sections ahead explore best practices, common oversight pitfalls, and practical steps for making revalidation a stronger program integrity tool.
Best Practices Around Revalidation
Effective revalidation is not limited to a fixed calendar event. Many organizations establish a baseline review every three to five years and supplement it with reviews triggered by meaningful risk indicators.
The following practices help organizations identify risk earlier, strengthen program integrity, and improve coordination across functions.
Use risk-based triggers: Review providers when meaningful signals arise, such as ownership changes, exclusions or sanctions, billing shifts, complaints, or investigative leads.
Use multiple data sources: Combine external sources such as the OIG List of Excluded Individuals and Entities (LEIE), SAM.gov, state Medicaid exclusion lists, the National Practitioner Data Bank (NPDB), and CMS systems such as PECOS and NPPES, with internal claims and case data for a more complete view of provider risk.
Document decision logic: Maintain clear rationale for escalations, documentation requests, targeted monitoring, and final review decisions to close or advance a concern.
Coordinate across functions: Revalidation works best when credentialing, compliance, medical review, and investigative teams share relevant findings and align on follow-up actions rather than operating in silos.
💡 Revalidation aligns with established program integrity expectations.
CMS treats revalidation as foundational to maintaining accurate enrollment data and billing privileges, and OIG exclusion screening remains a core component of payer oversight.
Federal regulations reflect this emphasis, with Medicare providers required to revalidate enrollment at least every five years (every three years for Durable Medical Equipment (DME)) under 42 CFR 424.515. Medicaid programs operate under a similar standard in 42 CFR 455.414, with increased focus on higher-risk providers.
Why Revalidation Is a Stronger FWA Tool Than Recredentialing
Recredentialing remains important, but it is not designed to serve as a primary FWA tool. It confirms that providers continue to meet network participation standards, while revalidation evaluates whether a provider’s current status, conduct, affiliations, and billing eligibility still support appropriate payment.
From a program integrity perspective, revalidation is stronger because it is:
More current: It can be triggered by risk signals instead of waiting for a fixed credentialing cycle.
More relevant to oversight: It focuses on exclusions, disclosures, affiliations, billing eligibility, and other indicators that help medical review and investigative teams act sooner.
More actionable: Findings can support escalations, payment review, documentation requests, or targeted monitoring before losses grow.
💡 The goal is not to replace recredentialing, but to recognize that recredentialing alone often cannot address evolving program integrity risks.
The 4 Pitfalls of Relying on Recredentialing
When organizations rely too heavily on recredentialing as their primary oversight tool, several gaps can weaken prevention and program integrity efforts.
Pitfall #1: Delayed visibility into risk. Long recredentialing cycles may allow exclusions, ownership changes, or suspicious activity to go undetected until after exposure has already increased.
Pitfall #2: Overreliance on static qualifications. A provider may remain licensed and credentialed while still presenting billing, enrollment, or behavioral risks that affect payment integrity.
Pitfall #3: Fragmented oversight. When credentialing, SIU, and medical review are not aligned; critical findings may not reach the teams best positioned to act.
Pitfall #4: Limited audit defensibility. Without timely reassessment of evolving risk, organizations may struggle to demonstrate a proactive and effective program integrity model.
💡 These pitfalls highlight why revalidation is often necessary to complement, and in some cases strengthen, traditional recredentialing approaches.
Recommended Actions
Organizations looking to strengthen provider oversight should take the following steps:
Define revalidation with a clear purpose: Establish a definition that supports prevention, payment integrity, and case development, not just regulatory compliance.
Incorporate risk-based triggers: Use signals such as claims anomalies, complaints, sanctions, ownership changes, and investigative leads to prompt review.
Integrate revalidation into operational workflows: Route findings to SIU, medical review, or compliance teams with clear escalation paths and defined actions.
Standardize documentation and decisioning: Maintain clear records of screening results, review outcomes, and rationale to support audit readiness and defensibility.
💡 Together, these actions help organizations move from periodic validation to continuous, risk-informed oversight.
Conclusion
For program integrity leaders, revalidation should be viewed as a core oversight capability, not just a regulatory requirement. As a program integrity tool, it provides a structured way to confirm that providers remain eligible, legitimate, and appropriate to receive payment.
Used effectively, it helps organizations detect change earlier, strengthen case development, and respond to evolving risk before it becomes a larger exposure. While recredentialing still plays an important role, revalidation should serve as a more central, active tool within a modern oversight strategy.
Integrity Advantage is Here to Help
Whether it is conducting FWA program assessments, strengthening internal processes, or providing outsourced SIU support, Integrity Advantage partners with healthcare organizations nationwide to turn insights into action. Together, we help teams move from goals to measurable progress. Integrity Advantage is a certified Women’s Business Enterprise (WBE) and Woman Owned Small Business (WOSB).
With more than 30 years of experience supporting payers, the team at Integrity Advantage provides healthcare fraud, waste and abuse consulting, outsourced investigations and medical record reviews for Special Investigations Units and other organizations fighting healthcare fraud. We are a certified Women’s Business Enterprise (WBE) and an Economically Disadvantaged Woman Owned Small Business (EDWOSB).
For more information click below, call us at 866-644-7799 or email info@integrityadvantage.com.